[Central metabolism of dopamine and serotonin. II. Significance of cerebrospinal fluid HVA and 5-HIAA changes in extrapyramidal and cerebellar syndromes].
D001480:Basal Ganglia Diseases / Q000134:cerebrospinal fluid*; D001921:Brain / Q000378:metabolism*; D002526:Cerebellar Diseases / Q000134:cerebrospinal fluid*; D004298:Dopamine / Q000378:metabolism*; D004827:Epilepsy / Q000134:cerebrospinal fluid*; D006719:Homovanillic Acid / Q000134:cerebrospinal fluid*; D006801:Humans; D006816:Huntington Disease / Q000134:cerebrospinal fluid*; D006897:Hydroxyindoleacetic Acid / Q000134:cerebrospinal fluid*; D008787:Metoclopramide; D010300:Parkinson Disease / Q000134:cerebrospinal fluid*; D010648:Phenylacetates / Q000134:cerebrospinal fluid*; D011339:Probenecid; D012701:Serotonin / Q000378:metabolism*
D010648:Phenylacetates; D012701:Serotonin; D006897:Hydroxyindoleacetic Acid; D008787:Metoclopramide; D011339:Probenecid; D004298:Dopamine; D006719:Homovanillic Acid
Contributo allo studio del metabolismo centrale della dopamina e della serotonina II. Significato delle modificazioni di HVA e 5-HIAA liquorali nelle sindromi extrapiramidali e cerebellari